USPH

Business Context and Reporting Period

Company: U.S. Physical Therapy, Inc.
Filing Type: Form 10-Q (Quarterly Report)
Period Ended: September 30, 2004
Business Overview: The Company operates outpatient physical and occupational therapy clinics providing pre- and post-operative care. As of September 30, 2004, it operated 254 clinics in 35 states. The Company primarily operates through subsidiary clinic partnerships, though it has increased its focus on wholly-owned clinics and partnerships while reducing profit-sharing arrangements.

Key Financial Metrics

Liquidity & Debt: The Company reported a current ratio of 8.52 to 1.00. Following the conversion of the remaining $1.7 million of its Series C Convertible Subordinated Note into common stock in June 2004, the Company has no funded debt and a debt-to-equity ratio of 0.0 to 1.00.

Material Changes vs. Prior Period

• Revenue Growth: Net revenues increased 10.6% in the third quarter and 12% for the nine months ended September 30, 2004, compared to the prior year periods. This was driven by an 8.2% increase in patient visits and a 3.1% increase in revenue per visit due to contractual fee increases.
• Profitability Decline: Despite revenue growth, Net Income decreased 44.6% in the third quarter (from $1.9M to $1.1M) and 18% for the nine months (from $5.9M to $4.9M). Diluted EPS fell from $0.15 to $0.08 in the quarter and from $0.48 to $0.40 for the nine months.
• Closure Costs: The Company recognized $815,000 in closure costs during the third quarter of 2004 related to the shutdown of eight unprofitable clinics. This included lease obligations, unamortized leasehold improvements, and severance.
• Corporate Expenses: Corporate office costs increased 11% in the quarter and 23% for the nine months. Increases were attributed to CEO search recruiting fees ($220,000), a one-time severance charge for the former CEO ($650,000), and higher legal/accounting fees related to Sarbanes-Oxley compliance.
• Asset Sale: The Company recorded a gain of approximately $443,000 on the sale of a clinic in June 2004.

Guidance, Outlook, and Risks

• Strategic Shift: Management announced a refocus on traditional partner and profit-sharing models, deemphasizing the opening of 100% company-owned clinics. The goal for 2004 is to open between 34 and 38 new clinics.
• Leadership Changes: Chris Reading was promoted to President and CEO, and Larry McAfee to Executive Vice President, effective November 1, 2004, following the resignation of former CEO Roy Spradlin.
• Medicare Limit Risk: Approximately 21% of revenues are derived from Medicare. A moratorium on the $1,590 annual Medicare therapy limit is in place through 2005. If the moratorium is not extended after 2005, it could adversely impact future revenue and income.
• Capital Resources: The Company believes existing cash ($24.8M) and operating cash flows are sufficient to fund operations and development through at least 2005 without external credit lines.

Investor Verification Checklist

• Closure Cost Impact: Verify the long-term impact of closing eight clinics on future revenue streams and the adequacy of the $815,000 provision.
• CEO Transition Costs: Confirm the total one-time costs associated with the former CEO's departure and the new CEO search, and assess if these are recurring.
• Medicare Exposure: Monitor the status of the Medicare therapy limit moratorium and the Company's strategy to mitigate potential revenue caps post-2005.
• New Clinic Performance: Track the ramp-up period for the 24 new clinics opened in the first nine months of 2004 to ensure they meet projected visit and revenue targets.
• Debt-Free Status: Confirm the Company maintains its debt-free status and does not require new credit facilities to fund the planned opening of 10-14 additional clinics in late 2004.